According to Veracyte's latest financial reports the company's current revenue (TTM) is $0.36 B. In 2022 the company made a revenue of $0.29 B an increase over the years 2021 revenue that were of $0.21 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.36 B | 21.76% |
2022 | $0.29 B | 35.09% |
2021 | $0.21 B | 86.85% |
2020 | $0.11 B | -2.4% |
2019 | $0.12 B | 30.82% |
2018 | $92 M | 27.87% |
2017 | $71.95 M | 10.55% |
2016 | $65.08 M | 31.48% |
2015 | $49.5 M | 29.62% |
2014 | $38.19 M | 74.51% |
2013 | $21.88 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Exact Sciences EXAS | $2.49 B | 592.36% | ๐บ๐ธ USA |
Myriad Genetics MYGN | $0.75 B | 108.61% | ๐บ๐ธ USA |
Biocept
BIOC | -$3.44 M | -100.95% | ๐บ๐ธ USA |